$CGBD Cashflow Statement | Understand Stock

$CGBD

$10.49 +$0.23 (2.24%) Close

$CGBD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Amortization of deferred financing costs and debt issuance costs
Net accretion of discount on investments
Paid-in-kind interest
Net realized (gain) loss on investments
Net realized currency (gain) loss on non-investment assets and liabilities
Net change in unrealized (appreciation) depreciation on investments
Net change in unrealized currency (gain) loss on non-investment assets and liabilities
Net change in unrealized (gain) loss on derivatives
Forward currency contracts
Interest rate swap
Total net change in unrealized (gain) loss on derivatives
Cost of investments purchased and change in payable for investments purchased
Proceeds from contribution of investments to Credit Fund II
Proceeds from sales and repayments of investments and change in receivable for investments sold
Cash acquired in CSL III Merger
Cash acquired in Credit Fund II Purchase
Changes in operating assets:
Interest receivable
Dividend receivable
Interest and dividend receivable
Prepaid expenses and other assets

Changes in operating liabilities:
Interest and credit facility fees payable
Base management and incentive fees payable
Administrative service fees payable
Other accrued expenses and liabilities

Net cash provided by (used in) operating activities
Cash flows from financing activities:
Proceeds from issuance of preferred stock
Repurchase of common stock
Borrowings on Credit Facilities
Repayments of Credit Facilities
Repayments of 2015-1R Notes
Repayments of Senior Notes
Proceeds from issuance of 2015-1N Debt
Proceeds from issuance of Senior Notes
Deferred financing costs and debt issuance costs paid
Proceeds from issuance of common stock from at the market offering, net of offering and underwriting costs
Dividends paid in cash
Net cash provided by (used in) financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of year
Cash, cash equivalents and restricted cash, end of year
Supplemental disclosures:
Interest and credit facility fees paid during the year
Taxes, including excise tax, paid during the year
Dividends declared on preferred and common stock during the year
Credit Fund II members’ interest received in consideration of contribution of investments (Note 6)
Dividends reinvested during the year

Supplemental disclosures of non-cash financing activities:
Common stock issued in Preferred Stock Exchange
Acquisition of CSL III
Non-cash assets acquired:
Investments, at fair value
CSL III Merger
Acquisition of Credit Fund II
Interest receivable
CSL III Merger
Acquisition of Credit Fund II
Other assets
Total non-cash assets acquired
CSL III Merger
Acquisition of Credit Fund II
Liabilities assumed:
Debt
Interest payable
Incentive fee payable
Derivative liabilities, at fair value
Other liabilities
CSL III Merger
Acquisition of Credit Fund II
Total liabilities assumed
CSL III Merger
Acquisition of Credit Fund II
Issuance of common stock pursuant to CSL III Merger
Consolidation of investments in Credit Fund II
Transaction costs capitalized into purchase price
CSL III Merger
Acquisition of Credit Fund II

Comments